全文获取类型
收费全文 | 3002篇 |
免费 | 193篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 74篇 |
妇产科学 | 73篇 |
基础医学 | 351篇 |
口腔科学 | 40篇 |
临床医学 | 265篇 |
内科学 | 653篇 |
皮肤病学 | 84篇 |
神经病学 | 146篇 |
特种医学 | 44篇 |
外科学 | 427篇 |
综合类 | 112篇 |
一般理论 | 4篇 |
预防医学 | 181篇 |
眼科学 | 137篇 |
药学 | 262篇 |
中国医学 | 18篇 |
肿瘤学 | 313篇 |
出版年
2023年 | 32篇 |
2022年 | 76篇 |
2021年 | 156篇 |
2020年 | 83篇 |
2019年 | 90篇 |
2018年 | 110篇 |
2017年 | 70篇 |
2016年 | 100篇 |
2015年 | 110篇 |
2014年 | 110篇 |
2013年 | 152篇 |
2012年 | 244篇 |
2011年 | 247篇 |
2010年 | 146篇 |
2009年 | 94篇 |
2008年 | 168篇 |
2007年 | 190篇 |
2006年 | 142篇 |
2005年 | 139篇 |
2004年 | 121篇 |
2003年 | 107篇 |
2002年 | 88篇 |
2001年 | 43篇 |
2000年 | 35篇 |
1999年 | 37篇 |
1998年 | 18篇 |
1997年 | 14篇 |
1996年 | 14篇 |
1995年 | 21篇 |
1994年 | 11篇 |
1993年 | 8篇 |
1992年 | 30篇 |
1991年 | 18篇 |
1990年 | 15篇 |
1989年 | 10篇 |
1988年 | 7篇 |
1987年 | 13篇 |
1986年 | 12篇 |
1985年 | 13篇 |
1984年 | 13篇 |
1983年 | 10篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1979年 | 9篇 |
1973年 | 6篇 |
1972年 | 5篇 |
1971年 | 6篇 |
1970年 | 6篇 |
1969年 | 6篇 |
1968年 | 5篇 |
排序方式: 共有3205条查询结果,搜索用时 0 毫秒
71.
Maryellen Potts Kathleen B. Cartmell Lynne Nemeth Gautam Bhattacharjee Suparna Qanungo 《Journal of pain and symptom management》2018,55(5):1382-1397.e7
Context
To meet the growing need for palliative care in low-resource countries, palliative care programs should be evidence based and contextually appropriate. This study was conducted to synthesize the current evidence to guide future programmatic and research efforts.Objectives
This systematic review evaluated palliative care outcome measures, outcomes, and interventions in low-resource countries.Methods
After title searches, abstracts and full-text articles were screened for inclusion. Data were extracted to report on intervention models, outcome measures used, and intervention outcomes.Results
Eighteen papers were reviewed, reporting on interventions conducted across nine low-resource countries. These interventions evaluated home-based palliative care models; a community-managed model; palliative care integrated with hospitals, hospices, or HIV clinics; and models focused on patients' self-management. Three studies were randomized controlled trials. Other studies used nonrandomized trials, cohort studies, mixed methods, pre-post test evaluation, cost-accounting evaluation, and cross-sectional surveys. Thirteen studies measured physical outcomes, 10 using multidimensional instruments. Nine studies measured psychological outcomes, eight using multidimensional instruments. Nine studies measured social outcomes, seven using multidimensional instruments. Nine studies measured outcomes across multiple domains. Across outcomes evaluated, results were reported in the direction of benefit associated with palliative care interventions.Conclusion
Many palliative care intervention models exist to serve patients in low-resource countries. Yet, limited high-quality evidence from low-resource countries is available to document intervention outcomes. Rigorous experimental studies and greater measurement of multidimensional aspects of palliative care are needed to advance the science of palliative care in low-resource settings. 相似文献72.
73.
74.
Suneet Kaur Gautam Srivastava Amar Nath Sharma Ravinder S Jolly 《British journal of pharmacology》2015,172(9):2286-2299
Background and Purpose
Recently, we have described the use of caerulomycin A (CaeA) as a potent novel immunosuppressive agent. Immunosuppressive drugs are crucial for long-term graft survival following organ transplantation and treatment of autoimmune diseases, inflammatory disorders, hypersensitivity to allergens, etc. The objective of this study was to identify cellular targets of CaeA and decipher its mechanism of action.Experimental Approach
Jurkat cells were treated with CaeA and cellular iron content, iron uptake/release, DNA content and deoxyribonucleoside triphosphate pool determined. Activation of MAPKs; expression level of transferrin receptor 1, ferritin and cell cycle control molecules; reactive oxygen species (ROS) and cell viability were measured using Western blotting, qRT-PCR or flow cytometry.Key Results
CaeA caused intracellular iron depletion by reducing its uptake and increasing its release by cells. CaeA caused cell cycle arrest by (i) inhibiting ribonucleotide reductase (RNR) enzyme, which catalyses the rate-limiting step in the synthesis of DNA; (ii) stimulating MAPKs signalling transduction pathways that play an important role in cell growth, proliferation and differentiation; and (iii) by targeting cell cycle control molecules such as cyclin D1, cyclin-dependent kinase 4 and p21CIP1/WAF1. The effect of CaeA on cell proliferation was reversible.Conclusions and Implications
CaeA exerts its immunosuppressive effect by targeting iron. The effect is reversible, which makes CaeA an attractive candidate for development as a potent immunosuppressive drug, but also indicates that iron chelation can be used as a rationale approach to selectively suppress the immune system, because compared with normal cells, rapidly proliferating cells require a higher utilization of iron. 相似文献75.
Mitchell W. Pesesky Tahir Hussain Meghan Wallace Bin Wang Saadia Andleeb Carey-Ann D. Burnham Gautam Dantas 《Emerging infectious diseases》2015,21(6):1034-1037
To characterize the genomic context of New Delhi metallo-β-lactamase-1 (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC), we sequenced 78 Enterobacteriaceae isolates from Pakistan and the United States encoding KPC, NDM-1, or no carbapenemase. High similarities of the results indicate rapid spread of carbapenem resistance between strains, including globally disseminated pathogens. 相似文献
76.
77.
Sharma Gautam Ghati Nirmal Doshi Shrenik Sharma Shruti Sharique Mohd Agarwal Aman Devagourou Velayoudam Hote Milind Padmakar Choudhary Shiv Kumar 《Journal of interventional cardiac electrophysiology》2022,64(3):621-628
Journal of Interventional Cardiac Electrophysiology - Late-onset atrial fibrillation (LOAF) after valve surgery for degenerative mitral valve disease often with underlying mitral valve prolapse is... 相似文献
78.
Opal SM Palardy JE Chen WH Parejo NA Bhattacharjee AK Cross AS 《The Journal of infectious diseases》2005,192(12):2074-2080
BACKGROUND: An experimental vaccine for sepsis, composed of detoxified Escherichia coli J5 lipopolysaccharide (LPS) complexed with the outer membrane protein (OMP) of Neisseria meningitidis group B, induces anti-core glycolipid antibody and has been tested in pilot studies in human volunteers. METHODS: Mice were immunized with the LPS-J5/OMP vaccine with or without synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs as a vaccine adjuvant (CpG ODN). The efficacy of the vaccine-induced antibody response was tested in a cecal ligation and puncture model. RESULTS: Immunization resulted in a >20-fold increase in anti-core glycolipid antibody levels, which were further increased 5-fold by the addition of CpG ODN, compared with the levels in mice in the control group. The vaccine provided a survival advantage after a cecal ligation and puncture was performed (P < .01) and significantly decreased the levels of bacteria in organs. Immunoglobulin G (IgG) anti-core glycolipid antibodies were decreased in mice to a significantly greater extent than were levels of total circulating IgG or IgG to the OMP part of the vaccine complex, suggesting specific epitope binding and clearance. CONCLUSIONS: These results indicate that the detoxified LPS-J5/OMP vaccine induces high levels of antibody against the core glycolipid of LPS and functions in vivo to promote clearance of gram-negative bacteria and improve the outcome of experimental polymicrobial intra-abdominal sepsis. 相似文献
79.
Maliha?Khan Tariq?Muzzafar Hagop?Kantarjian Ifra?Badar Nicholas?Short Xuemei?Wang Kamal?Chamoun Preetesh?Jain Courtney?DiNardo Naveen?Pemmaraju Prithviraj?Bose Gautam?Borthakur Jorge?Cortes Srdan?Verstovsek Guillermo?Garcia-Manero Zeev?EstrovEmail author 《Annals of hematology》2018,97(7):1183-1191
The impact of bone marrow fibrosis grade on the prognosis of patients with chronic myelomonocytic leukemia (CMML) remains controversial. Therefore, we examined the records of 82 patients diagnosed with CMML at our institution and summarized baseline characteristics and molecular profiles by subgroups of absent or mild (grades 0/1) and moderate (grade 2) fibrosis. Cox proportional hazards models were constructed to assess the prognostic significance of fibrosis grade. Grade 2 fibrosis was identified in 63 patients (76.8%), grade 1 in 16 patients (19.5%), and grade 0 in 3 patients (3.7%). Grade 2 fibrosis was associated with reduced hemoglobin levels (median 9.75 vs 11.0 g/dL in grade 0/1; p?=?0.04) and increased percentages of ringed sideroblasts (7.5 vs 0%; p?=?0.008). In multivariable analysis, grade 2 fibrosis was an independent predictor of poor overall survival (OS; 95% CI 1.32–6.35; HR 2.90; p?=?0.008), but not event-free survival (EFS; 95% CI 0.62–2.67; HR 1.28; p?=?0.50). Absolute neutrophil count (ANC) was found to impact OS (95% CI 1.01–1.09; HR 1.05; p?=?0.009), while both ANC (95% CI 1.00–1.07; HR 1.04; p?=?0.04) and peripheral blood blast percentage (95% CI 1.02–1.32; HR 1.16; p?=?0.02) impacted EFS. These results implicate fibrosis grade is an important indicator of prognosis, with high-grade fibrosis predicting inferior survival. Given the prevalence of marrow fibrosis in CMML, fibrosis grading should be incorporated into prognostic assessment and therapeutic decision-making. 相似文献
80.
Dhiman RK Sawhney MS Chawla YK Das G Ram S Dilawari JB 《Digestive diseases and sciences》2000,45(8):1549-1552
To investigate the role of lactulose in the treatment of cirrhotic patients with subclinical hepatic encephalopathy (SHE), 40 cirrhotic patients, 33 males and 7 females, were included in the study. The diagnosis of SHE was made by quantitative psychometric tests including the number connection test (NCT), figure connection test (FCT) parts A and B, and two performance subtests of Wechsler adult intelligence scale, ie, picture completion (PC) and block design (BD) tests. SHE was diagnosed in 26 (65%) of 40 patients. Of these 26 patients, 14 patients were randomized to treatment group (lactulose 30–60 ml/day for three months, SHE-L) and 12 patients to no treatment group (no lactulose, SHE-NL). Psychometric tests were repeated in all patients in both groups and in six patients with no SHE (group NSHE, N = 14) after three months. The mean scores and number of the abnormal psychometric tests at entry were significantly higher in patients in groups SHE-L and SHE-NL than in patients in group NSHE; however, there was no significant difference between SHE-L and SHE-NL. The mean number of the abnormal psychometric tests decreased in patients in group SHE-L after three months of treatment with lactulose (2.9 ± 0.9 vs 0.8 ± 1.2; P = 0.004); however, there was no change in patients in group SHE-NL after three months (3.7 ± 1.5 vs 3.5 ± 1.3; P = NS). While SHE improved in 8 of 10 patients in group SHE-L, none of the patients in group SHE-NL improved after three months of follow-up (P < 0.001). Two patients in group SHE-NL also developed overt encephalopathy during the study period. We conclude that lactulose treatment in cirrhotic patients with SHE is effective. 相似文献